ARISAN THERAPEUTICS INC

Federal contract awards won by ARISAN THERAPEUTICS INC (UEI PYRKTQPNVJZ8), 2021–2026 — public record from USAspending.

Showing awards with a value or ceiling of $250K+ active within the last 5 years. Need older history or smaller awards? Tell us what you need — we expand by request.

4
awards
2
expiring in 12 months
2
agencies

Category award history

1 category award to a new vendor (same agency and NAICS code, not this contract's own history) — latest: HEPBURN AND SONS LLC took Department of Defense 541715 work from ARISAN THERAPEUTICS INC (Jul 11, 2023).

Agencies buying from ARISAN THERAPEUTICS INC

Department of Defense (2)Department of Health and Human Services (2)

What ARISAN THERAPEUTICS INC has provided

541715 — RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY) (3)541330 — ENGINEERING SERVICES (1)

Awards

TO DEVELOP A THERAPEUTIC SMALL MOLECULE VIRAL ENTRY INHIBITOR AS A MEDICAL COUNTERMEASURE FOR FILOVIRUS INFECTION.
Department of Health and Human Services · $2,933,547 · Aug 3, 2026
TO CONDUCT NON-CLINICAL GOOD LABORATORY PRACTICE (GLP) IN VIVO GENOTOXICITY AND REPRODUCTIVE TOXICOLOGY AND GLP DEVELOPMENT AND REPRODUCTIVE (DART) TOXICOLOGY STUDIES.
Department of Health and Human Services · $3,692,037 · Sep 22, 2023
PHASE II - SBIR TOPIC CBD192-006
Department of Defense · $1,099,662 · Sep 30, 2021
PHASE II BASE PERIOD
Department of Defense · $526,794 · Sep 28, 2021